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D 4.4 Introduction to Interventional Treatment for Critical Limb Ischemia
The decision to proceed with vascular intervention on a patient with CLI is relatively straight-
forward, because most require revascularization to avoid major amputation. The decision
regarding the most appropriate intervention, however, is complex, with a number of factors
requiring consideration . In addition to the mortality and morbidity, comorbid risk factors and
life expectancy must be weighed against the initial success and long-term durability of the cho-
sen intervention. The literature can provide only broad direction in the decision-making process
because most series report best results in a selected patient population characterized by more
favorable anatomic lesions.
Ideally, the patient should be treated with the least risky and least morbid but most successful
and durable procedure. Comorbid risk factors wiII modify this ideal to give priority to patient
safety. High-risk, frail patients may be best treated with less invasive interventions, even though
durability may not be optimal. In some patients, revascularization procedures should be aban-
doned for primary amputation when patient factors suggest extremely high morbidity and mor-
tality or the arterial anatomy predicts a poor outcome of intervention. Conversely, the tempta-
tion to pursue the least invasive procedure even in the healthy individual should be resisted. In
such cases, the durability of the procedure over many years is important in reducing lifetime
morbidity and cost .
In the following discussions, the results of open surgical and endovascular procedures are pre-
sented separately in relation to proximal and distal levels of occlusive disease: aortoiIiac or
infrainguinal, This is followed by a discussion of the usually preferred option for each broad cat -
egory of lesion : aortoiliac or infrainguinal . The disease at each level not only must be consid-
ered in terms of its own severity, but all levels of disease must be combined in considering the
best approach to limb salvage and improved function . This is particularly true of CLI, in which
multilevel occlusive disease predominates and poor runoff is almost the norm . Although it is
necessary to present the results of open surgical and endovascular interventions separately, they
ultimately must be considered together. Unfortunately, there is a tendency to choose either sur-
gical or percutaneous revascularization techniques exclusively in a given patient, but a multidis-
ciplinary approach results in better choices, as may combining procedures. Excellent results may
be obtained when endovascular and open surgical procedures are combined (eg, combined iliac
dilatation with distal surgical revascularization).
Given the multilevel nature of the disease in patients with CLI and the lack of sufficient data in
the literature dealing with each of the multiple combinations of disease, it is not possible to
make recommendations that cover all eventuality, In principle, however, the most appropriate
treatment should be applied to each individual occlusive lesion, and combinations of treatment
modalities should be considered as well as procedures that span more than one level of disease .
These and the other considerations previously mentioned should be kept in mind in the discus-
sions that follow In the following sections, results from a variety of studies are presented. It is
imperative that the individual caring for the patient with e LI review the results obtained at
their own institution (see also Recommendation 77, p 5175, and D 4.15, Vascular Registry
Data, p 5261).
Recommendation 87: Choosing between teelmiques with comparable short- and long-term
benefit
When two techniques of revascularization (endovascular and open surgery) give equiva-
lent short-term and long-term benefit, the technique with the least morbidity and mor-
tality must be used first. Cost also should be considered.
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Recommendation repeatedfrom previoussection) see p S175
Recommendation 77:
It is recommended that all units dealing with critical limb ischemia maintain accurate,
audited recordsfor patients treated and their progress. The minimum follow-up analysis
should be in terms of i-year re-interventions, re-admissions, amputation rates, mortality,
and, ideally, other outcome measures.
D 4.5 Aortoiliac Disease-Surgical Treatment
D 4.5.1 Introduction
The surgical treatment of aortoiliac disease offers better results, in terms of degree and duration
of benefit, than surgical treatment of more distal lesions. However, it is also generally associated
with greater morbidity than infrainguinal reconstruction, although the mortality risk is similar,
primarily because of the higher incidence of diabetes (and thus systemic atherosclerosis) in the
latter group.! Whether one is dealing with primarily unilateral (iliac artery) occlusive disease or
bilateral disease (aortoiliac or bilateral iliac) has major bearing on the choice of treatment and
particularly the choice between bypass or endovascular revascularization. To permit the separa-
tion of bilateral (usually more diffuse) disease from more localized unilateral disease, operations
to treat each of these conditions have been addressed separately.
D 4.5.2 Bilateral Disease
The aortobifemoral bypass
The aortobifemoral bypass (ABF) is considered the reference standard of treatment for aortoiliac
occlusive disease, because it produces the best and most reliable overall results (see Table 42).
However, because most patients with claudication and limited lesions are now treated by
endovascular procedures, ABF is in general reserved for those with extensive lesions and eLI
rather than those with claudication. The stability of modern graft materials and the durability of
benefit in those patients who have undergone ABF grafting is such that other revascularization
procedures for aortoiliac disease must be compared with it. A number of alternatives to the stan-
dard approach through a vertical incision have been suggested, including a transverse incision.?
retroperitoneal.f and more recently, minimally invasive and laparoscopic approach.t Overall
patency rates are not different when end-to-end versus end-to-side upper anastomoses are prop-
erly compared. 5,6,7 Therefore, other considerations should dictate the configuration of the aortic
anastomosis. These include preservation of blood flow into the inferior mesenteric and internal
iliac arteries, preservation of the hypogastric arteries, which may reduce the incidence of impo-
tence, aneurysmal changes, the aorta as a source of emboli, and juxtarenal aortic occlusion.
Aortoitiac endarterectomy
The durability of aortobifemoral bypass grafting led to a decrease in the performance of this
more technically challenging operation. Most centers reserve endarterectomy for young patients
with very localized disease, but, for the most part, aortoiliac endarterectomy now competes
(unfavorably) with PTA and stenting.
The possible requirement for future aortic surgery should temper enthusiasm for this procedure
except in the ideal patient.f Risks of infection are low, and internal iliac flow is preserved. It
avoids the risk of graft infection, and this promotes its use in patients with an ongoing increased
risk of sepsis caused by infectious diseases elsewhere (eg, recurrent urinary sepsis). In one study,
a lO-year patency rate of90.4% was reported, but in over half of these patients the indication
for surgery was claudication, and other authors have not attained similar good results.? Selected
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Table 42: Primary patency results for aortobifernoral bypass ranked by percentage CLI patients and total
sample size (selected reports)
Primary patmcy (%)
OptratiJle
Patients %CLI mortality (%) lyr 3 yrs 5 .Yl's ltlyrs Comments
>50% patients with CU
Prcndiville 134 limbs 75 3 94- 89 CPA nnastomosis
et al, 199212
Prendiville 151 limbs 65 3 95 92 PFA anastomosis
et al, 19921l
Schneider 79 59 1.3 85
ct al, 1991 13
H arris 177 59 4 91 incl 23 unilat.
er al, 1985 14 procedures
Schneider 107 53 85
et ai, 199215
Nevelsteen 912 53 5 94 83
et al, 1991 16
Brewster & 261 52 1.9 99 95 91 data from 1970·77
Darling, 1978 17
<50% pnrimts with CLl
Mulcare 114 46 S.S 98 95
et al, 197~ 18
Ameli 105 42 5.7 93
et al, 1989 19
Littooy 224 37 4.9 97 90 88 73
et al, 199320
Dunn 192 36 3 96 89 86
et aI, 198221
Friedman 34 35 0 100 100 98 PTFE graft
et al, 199522
Friedman 26 31 0 100 100 93 Dacron graft
er ai, 199 5 22
Naylor 24 1 29 94 83 81
et al, 198923
Poulias 820 29 3.3 89 82
et al, 199224
Martinez et 376 28 5.6 95 92 81l 78
ai, 198025
Mason 59 25 7 92 89
er al, 198926
van den Akker 518 23 3.3 90
er al, 199221
Melliere III 22 1.8 91 end to side
et al, 19907
Jensen & 56 21 0 96 92 89%@4yrs
Egebh\d ,199029
van der Vleit 350 19 4.9 93.4 88.4 86.4 80.4
er al, 199430
results of primary patency rates for aortoiliac-fernoral endarterectomies are presented in Table
44, with 5-year paten cy rates ranging from 60% to 94%. Mo st studies have a low incidence of
operations for CLI, and where compa red, patency rates arc clearly better in patients treated for
claudication . More localized endarterectomies also offer more favorable results than those of
the entire aortofemoral segment.
D 4.5.3 Tabulated Results for Aor toiliac Reconstruction
Treatment comparisons of surgical and cndovascular modali ties are not always stratified into
unilateral (iliac artery) and bilateral (aorroiliac and bilateral iliac) disease in the reported litera-
ture. The excellent patency rates for aortobifemoral bypass grafts reflect good fimctional results
(see Table 42) . It sho uld be no ted that, in many of the stu dies cited, most subjects were
patients with intermittent claudication. Approximately 95% of patients are initially rendered
asymptomatic or improved, and after 5 years, approximately 80% to 90% remain in this catego-
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ry.lO A study from the United Kingdom indicates that, of patients fully employed before aorto-
bifemoral bypass, 85% return to £1.111 employment an average of 4 months after surgery'! 1 It
should be noted that in this table some older series, although reporting good patencies, not
unexpectedly have higher mortality rates .
In a meta-analysis of pooled data from 1978 to 1996, de Vries and Hunink-! showed that after
1975 the aggregate mortality rate had dropped from 4.6% to 3.3%, and the aggregate systemic
morbidity risk dropped from 13.1%to 8 .3% (Table 43 ). Importantly, this study compared limb-
based patency rates for patients with intermittent claudication and those with CLI. For claudica-
tion, they were 91 .0% and 86.8% at 5 and 10 years, respectively. This study confirms two previ-
ous observations of the superiority of ABF over other bypasses: (l) its remarkable durability and
(2) its patency is less affected by poor run-off, typified by CLI patients.
Table 43: Meta-analysis of primary patency in reconstructions performed after 1975 in patients with eLI 31
5-yc:ar primary parency:
Limb-based
Pntient -lmsed
10 -yc:ar pri ma ry patency:
Limb-based
Patient-bnsed
Opera tive mortality
Systemic morbidity
87 .5% (80n88)
80.4%(72-82)
81.8%(70- 85)
72.1%(61- 76)
3.3%
8.3%
Table 44: Results of primary patency rates from reportS of aortoiliofemoral endarterectomy (selected reports)
Operative Patency
Pati ents %CLI mortality (%) lyr 3 yrs 5 yrs
Roder er al, 198546 55 67 1.7 60
van den Dungen et al, 199147 93 39 0 94 83
Vitale & Inahara, 199048 60 35 0 88 86 80
O skam et al, 199649 94 11 0 83 68
Brewster & Darling, 197917 253 2.9 98 95 94
195 7.6 95 85 80
92 1 66
Lazaro er al, 198851 31 0 75
Comments
aortoiliac
aortoiliac-
fem oral
iliofemoral
aortoiliac
Axillofemoral bypass
The axillary artery may be used as an inflow source. Although some recent studies report excel-
lent results with extraanatornic bypass grafts, such as axillofemoral bypasses, these are in general
limited to th ose patients with exceptional surgical risks because of concurrent disease or to those
in whom the abdominal approach is contraindicated (eg, infection, multiple adhesions, other
intraabdorninal pathological conditions) . The improved recent results with 5-year primary
patencies of 75% to 80%are related to technical improvements. These include the use of exter -
nally supported prostheses52,53 but liberal ized indications also may playa role. In comparable
cases, ABF produces better patency, but axillobifernoral bypass produces lower morbidity and
mortality. This tradeoff is more difficult to justify in good-risk patients with intermittent claudi -
cation but it is clearly valuable in those with eLI when there is a mandatory requirement for
femoral inflow and the direct abdominal approach is contraindicated by a prohibitive risk.
Adequate inflow for axillofernoral bypasses needs to be confirmed by duplex scan before opera-
tion. Calligaro et al54 recommended inflow arteriography because they found both a higher
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incidence of inflow disease (25%) and the failure of noninvasive examination to detect disease in
75% of patients found to have significant stenoses with arteriography,
Results of axillounifemoral and axillobifemoral bypass grafts are presented in Table 45. Primary
patency results at 5 years (axillounifernoral, 30% to 79%; axillobifemoral, 33% to 85%) are not as
good as tho se for aortobifemoral bypass grafts . In series in which th e two have been compared,
patency rates have been statistically significantly better for axillobifemoral than for axil-
lounifemoral bypass, or the mean patency rates have favored the former. However, the cases may
not be truly comparable, and the issue of whether to always perform a bilateral bypass even in
the face of unilateral ischemia has never been addressed by an appropriate trial ,55,56,57,58
Table 45: Results of aortoiliac procedures-primary patency rates for extraanatomic bypass (selected reports)
Primary patmcy (%)
Operative - - - --
Patients cu (%) mortality (%) l yr 3yrs 5 yrs
Axillounifemoral
Asccr et al, 198555 34 100 5 44
Rutherford et al, 198737 27 100 13 48 19 19
Chang, 198641 23 100 33
Naylor er al, 199042 17 100 11 50
Hepp et al, 198834 90 80 5
Harrington eral, 199443 73 71 8.3
EIMassry et ai, 199344 50 62 5 79
Axil/obijemoral
Chang, 198641 26 100 75
Asccret al, 198555 22 100 5 50
Naylor ct al, 1990H 17 100 11 68
Rutherford er al, 198737 15 81 11 78 62 62
Passman er ai, 199653 108 80 3.4 90 74 74
Hepp et aI, 198834 22 80 5
EI Massryet al, 199344 29 62 5 76
Harrington et ai, 199443 80 50 8.3
Harris ct al, 199052 76 5 93 85 @4yr
Axillopoplitcal
Ascer etal, 198555 55 100 8 58 45 40
Keller et al, 199245 41 100 20 70 43
Critical Issue 32: AWlobifemoral versus axillounifemQral b~ass fQr critical limb ischemia
There is a need to determine whether a bilateral procedure should always be performed,
even in the case of unilateral ischemia, when constructing an axillofemoral bypass.
Thoracofemoral bypass
The thoracic aorta may provide a suitable inflow artery in patients with reasonable pulmonary and
cardiac function . Most authors find that the use of the descending thoracic aorta with a retroperi-
toneal tunnel provides more acceptable operative risk and acceptable patency rates.59,60,61 The
proximal anastomosis is performed through a lower thoracotomy with retroperitoneal tunneling
and crossover femoral grafting to provide inflow to both legs. Five-year patency rates of 86% have
been reported.59
Special considerations in proximal surg ical revascularizations
Management ofjuxtarenal aortic occlusion (aortofe moral bypass)
Aortic occlusion pro gressing to the juxtarenal position may be treated successfully by an aortob-
ifemoral bypass graft . The aorta must be thrombo-endarterectornizcd, eith er through the end of
the divided infrarenal aorta ("champagne cork" operation) or through a longitudinal arterioto-
my in the infrarenal position after the renal arteries have been protected from embolization.62,63
The additional morbidity has been reported specifically with respect to suprarenal clamping and
renal failure as long as the clamping time of renal arteries is less than 30 minutes and there is no
embolization of thrombotic or atheromatous debris into the renal circulation.
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Management ofthe small «hypoplastic» aorta
A subset of patients, mainly female, have congenital markedly small aortas . There remains con-
troversy about the best treatment for these patients. Aortoiliac endarterectomy with a patch has
been advocated by some, but the commonly preferred alternative is to use an ABF with a wide
end-to-side anastomosis. This gives acceptable results with meticulous technique.vt .
Management of coexisting infrainguinal occlusive disease
Many, jf not most, patients with CLI have multilevel disease. Brewster ct al65 reported that 49%
of patients undergoing aortobifemoral bypass grafts would have occlusion of the superficial
femoral artery. Many authors have written about the ability to predict the success of an inflow
procedure alone to relieve symptoms and salvage the limb. The need for subsequent bypass has
been estimated to be as high as 21% to 25%, although in Brewster et al's series only 4% were
done simultaneously.65,66 One aspect of this is assessment of the hemodynamic significance of
iliac stenoses. It is accepted that inflow must be adequate before the performance of an outflow
procedure. Complete occlusions are easy to assess ang iographically, but stenoses are difficult to
gauge. Hemodynamically significant stenoses may be missed on AP projections because iliac
plaques build up posteriorly. Even biplanar views may misjudge them . Conventional thinking is
that proximal revascularization will suffice in most cases (approximately 75%-85%) . Identifying
characteristics of the remainder include (1) the proximal lcsion is of modest hemodynamic sig-
nificance; (2) there is occlusive disease in the profundageniculate collateral pathway beyond that
which can be dealt with by concomitant profundaplasty; (3 ) the popliteal artery or two of its
branches are occluded (poor runoff); and most importantly, (4) there is major tissue loss or
infection in the foot.
The measurement of pressure gradients across the aortoiliac segment after the administration
such as papaverine has been deemed a suitable assessment of aortoiliac stenosis in determining
the need for an inflow versus an outflow procedure.P?Occasionally a drop in pressure will be
evident only after distal reconstruction, and therefore these pressures should be monitored.sf
There was no difference in infrageniculate graft patency at 4 years when the anatomic degree of
proximal iliac stenosis is compared.s? It must be stressed that it is the systolic component of the
arterial pressure that most accurately reflects tile underlying hemodynamic status of the arterial
segment being examined.70,71 Although pressure gradient measurement can be done readily
during preprocedural arteriography, it is less desirable as a separate procedure. For this reason,
noninvasive imaging has been explored as a substitute. The mean sensitivity of the clinical evalu-
ation for aortoiliac disease has been reported to be in the range 32%to 77%, which is not ade-
quate for routine screening.72
Duplex scanning was found to be tile most reliable single noninvasive test for aortailiac disease,
with a mean sensitivity of 92%.73 Although duplex scanning usually gives a clear result , occa-
sionally lesions are close to tile threshold between hemodynamically significant and insignificant
lesions, and it is not possible in some patients (eg, because of obesity or intestinal gas). MRA is
gaining reco gnition as an appropriate assessment of aortoiliac occlusive disease (sensitivity, 92%;
specificity, 88%),74 Such borderline lesions require intraarterial pressure measurement with
hyperemia at the time of arteriography. Hyperemia can be induced either pharmacologically or
mechanically, Such measurements ideally should be performed before reconstruction but also
can be performed at time of surgery on the operating table. Contrast arteriography with pres-
sure measurements, both at rest and after vasodilatation, is considered to be tile reference stan-
dard, but duplex can distinguish all but the borderline lesions with accuracy,?5,76,77,78,79 There
remains considerable controversy over what constitutes the threshold value for hemodynamically
significant pressure gradients, but it is generally accepted that peak systolic differences of 5 to 10
mm Hg at rest and 10 to 15 nun Hg after vasodilatation are important (see B 4.3.3, Aortoiliac
Stents, p SlOl).
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Recommendation 88: Intraarterial pressure measurements for assessment of multilevel disease
In a patient with multilevel disease, if there is doubt about the hemodynamic signifi-
cance of partially occlusive aortoiliac disease, it should be determined by intraarterial
pressure measurements at rest and with induced hyperemia before constructing an out-
flow bypass. This may be performed at the time of angiography.
Repeated from p 5102
Critical Issue 11: Use of pressure gradients to assess hemodynamic significance of stenoses
Pressure gradient criteria with or without vasodilators for assessing hemodynamic sig-
nificance in iliac lesions remain to be established.
Critical Issue 33: Effect of distal disease on iliac artery pressure gradients
There is a need for future studies to investigate the extent to which severe distal disease
may cause an underestimation of translesion iliac artery pressure gradients.
Presuming significant proximal disease requiring revascularization is present, the other main
consideration is whether the coexisting distal disease must be dealt with by concomitant bypass
or profundaplasty, or whether a proximal revascularization alone will suffice. Most agree that
major tissue loss or infection in the foot is an overriding consideration. In the absence of that
finding, the choice regarding profundaplasty versus distal bypass is still a matter of debare.sv
The profunda is a durable outflow artery, and, in the presence of a superficial femoral artery
occlusion and stenosis of the origin of the profunda femoris artery, a profundaplasty should be
performed at the time of ABF. The value of concomitant profundaplasty when the proximal
profunda is narrowed is well established.
Even if profundaplasty is indicated and performed, decisions regarding the need for concomi-
tant bypass, related to indication (3) previously discussed, needs to be made, and this can be
aided by segmental limb pressure. The pressure index recommended for isolated profundaplasty
is less useful in the face of a proximal revascularization. However, attempts have been made to
predict the need for concomitant distal bypass from hemodynamic data. Rutherford et al5 were
able to develop a proportion formula relating the preoperative thigh and ankle brachial indices.
This "predicted" (correlated with the presence or absence of) hemodynamic failure when distal
reconstruction was not performed with 89% accuracy. 5 Others have successfully incorporated
this approach into their practices.w
D 4.5.4 Unilaterallliac Disease
Unilateral aorto or iliac to femoral bypass
When a single iliac artery is involved in the ischemic process, it may be desirable to conduct a
unilateral procedure. Several studies suggest that unilateral aorta femoral bypass grafts can be
safely performed and may have higher patency rates than extraanatomic bypass grafts. 8] The iliac
artery also may provide a suitable inflow artery.82,83,84 The risk ofprogression ofocclusive dis-
ease in the contralateral iliac artery and the need for subsequent reconstruction has given rise to
cautionary note by some authors who prefer to perform a bilateral reconstrllction.85,86
Femorofemoral bypass
Comparativestudies have failed to yield comparable successrates for extraanatomic bypass grafts
when compared with the standard ABF, probably attribtable in part to progressive diseasein the
donor limb.87,88 Thus, the inflow arterial system must be ofan excellent quality ifgood results are ro
be obtained with crossover bypasses. Inflow may be improved with PTA before crossover femoral
grafting in those with some donor iliac artery stenosis. Comparative studies have shown similar
patencyrateswhen donor arteries are dilated or stented before bypass in carefi.illy selectedpatients.89
It is recommended that donor iliac artery PTA or stenting should be reservedfor the ideal lesions.
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Results of direct revascularization and crossover grafts are depicted in Table 46. Controversy
exists over which of the two main choices of operation is preferred. In addition, unless the dis-
ease is truly localized to the unilateral iliac system or the patient's condition precludes an aortic
procedure, ABF is recommended as the inflow procedure of choice.s?
Table 46: Results of aortoiliac procedures-primary patency rates for unilateral reconstruction (selected reports)
Operative Primal') patency (%)
eLl mortality ) -- -----
Patients (%) (% 1.'11" 3Yl" Syr Comments
Unilateral aorto/illaciliac/femoral bypass
Piotrowski et al, 198885 17 53 0 48 48 tcompare with fem-fem results belowt
Kalman et al, 1987~2 50 44 0 96 92
van der Vleit et al, 1994 30 184 39 2 95 88
Mason cr al, 1989 26 39 31 0 89
Ricco, 199233 69 18 I 97 90 :j:comparewith fem-fern results below+
Femorofemoral bypass
Hepp et aI, 198834 26 80 4 100 80
Lorenzi er al, 199435 165 67 4.2 91 81 75
Kalman er al, 198736 82 52 0 80 6773
Perler & Williams, 1996 89 26 46 1.4 87 79 79
Perler & Williams, 199689 44 50 1.4 81 73 59 with donor artery dilatation
Rutherford et al, 198737 60 45 0 79 67 67 without donor artery dilatation
Criado et al, 199338 110 44 4.5 83 71 60
Piotrowski et al, 198885 47 40 0 60 55 tcompare with iliofem results above'l
Ng er al, 1992 39 156 34 1.3 92
Ricco 199233 74 17 1 92 79 :j:comparewith iliofem results abovet
Farber 199040 71 4 82
Chang 19864 1 53 85
Critical Issue 34: Long-term results of crossover bypass grafts
There is a need for randomized studies comparing long-term results of crossover femo-
rofemoral bypass, iliofemoral bypasses, or endarterectomy and direct aortofemoral
bypasses.
Axillounifemorai bypass
The application of this bypass is limited, because of its lower patency rate, primarily to sec-
ondary operations for graft infections. It also is used in situations in which there is a pressing
need for unilateral inflow but other inflow donor arteries are not patent or accessible because of
hostile anatomy or prohibitive anesthetic risk (see also Table 45, p S208).
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D4.6 Aortoiliac Disease-Endovascular Treatment
For a detailed discussion of endovascular treatment of aortoiliac disease, see B 4 .3.2, Aortoiliac
PTA, p S98. Endovascular techniques such as PTA and stent placement have the advantage of
lower morbidity and mortality risk compared with open surgical revascularizations.l The death
and complication rates of aortoiliac PTA and stent placement were analyzed in a meta -analysis of
2,116 reported patients.Z Death within hospital stay (not 30-day mortality) averaged 0.14% for
PTA and 0.3% for stcnt procedures. The 30-day mortality rate averaged 0.8% for PTA and 1.0%
for stem procedures (For detailed discussion of complications of endovascular procedures, see B
4 .3.7, P Sl09). The mean systemic complication rate was 1.3%; the local complication rate,
9.6%; and the mean rate of major complications necessitating treatment was 4.3% for PTA and
5.2% for stents, respectively.- .
Endovascular procedures are generally performed on patients with less severe disease than those
undergoing surgical treatment. The risk tor endovascular technique is much lower than for sur-
gical treatment. However, PTA and stents offer a lower durability of the result as compared with
bifurcated graft surgery. The adjusted 4-year primary patency rate for treatment of eLI, with
technical failures included, was 53% after PTA and 67% after stent placement for the treatment
of stenoses.V Analysis of variables that could potentially affect the patency results shown some
hete rogeneity. However, disease severity (e LI vs claudication), lesion type (occlusion vs steno-
sis), and lesion site (common vs external iliac) were found to affect patency in some studies.4,5
An analysis of the results of the endovascular treatment of aortoiliac disease has already been
presented (see B 4.3.2, Aortoiliac PTA, p S98, and B 4.3.3, Aortoiliac Stents, p S101 ) and is
not repeated here. This is because these procedures have been predominantly performed for
claudication (proportion of patients undergoing procedures for claudication: 77% of PTA per-
formed for iliac stenoses, 82% of iliac PTA for occlusions, 78% of iliac stenting for stenosis, and
86% of iliac scenting for occlusion). It should therefore be pointed out, in reviewing these data
in comparison with the surgical bypass data presented earlier (see D 4.5.3, p S206), that the
